Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antigen receptor-expressing T cells as anti-cancer therapeutics

Chimeric antigen receptor-expressing T cells as anti-cancer therapeutics

US Patent 12150981 · Granted Nov 26, 2024

Estimated economic value: $1,070,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses ther2025
PSMA binding ligand-linker conjugates and methods for using2025
Cholecystokinin B receptor targeting for imaging and therapy2025
Inhibitors of erythrocyte band 3 tyrosine phosphorylation and uses thereof2025
Compounds and methods for the treatment and prevention of fibrotic disease state2025
Fibroblast activation protein (FAP)-targeted imaging and therapy2025
Targeted ligand-payload based drug delivery for cell therapy2025
Targeting anabolic drugs for accelerated fracture repair2025
Methods of use for CAR T cells2025
Methods of use for CAR T cells2025
Sequencing method for CAR T cell therapy2025
Sequencing method for CAR T cell therapy2025